000 01382 a2200373 4500
005 20250517200427.0
264 0 _c20190320
008 201903s 0 0 eng d
022 _a1938-0666
024 7 _a10.1016/j.clbc.2017.12.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYeruva, Sri Lakshmi Hyndavi
245 0 0 _aComplete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report.
_h[electronic resource]
260 _bClinical breast cancer
_c06 2018
300 _ae277-e280 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAged
650 0 4 _aBreast Neoplasms
_xdiagnosis
650 0 4 _aCarcinoma, Intraductal, Noninfiltrating
_xdiagnosis
650 0 4 _aChemotherapy, Adjuvant
_xmethods
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMastectomy
650 0 4 _aNeoplasm Recurrence, Local
_xpathology
650 0 4 _aPiperazines
_xtherapeutic use
650 0 4 _aPostmenopause
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aPyridines
_xtherapeutic use
650 0 4 _aTreatment Outcome
700 1 _aJavadi, Mehrbod Som
700 1 _aStearns, Vered
773 0 _tClinical breast cancer
_gvol. 18
_gno. 3
_gp. e277-e280
856 4 0 _uhttps://doi.org/10.1016/j.clbc.2017.12.008
_zAvailable from publisher's website
999 _c28042047
_d28042047